Innate Pharma saw the highest growth of 899% in patent filings and 149% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 12% and grants by 132%. GlobalData’s DataBook provides a comprehensive analysis of Innate Pharma‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Innate Pharma has been focused on protecting inventions in Australia(AU) with four publications in Q1 2024

The Australia(AU) Patent Office dominates the patent filings and grants with nearly 18% filings and 20% grants. The Australia(AU), China(CN), Brazil(BR), and European Patent Office(EPO) patent Office are among the top ten patent offices where Innate Pharma is filings its patents. Among the top granted patent authorities, Innate Pharma has 30% of its grants in United States(US), 20% in Australia(AU) and 20% in China(CN).

F. Hoffmann-La Roche could be the strongest competitor for Innate Pharma

Patents related to addiction and rare diseases lead Innate Pharma's portfolio

Innate Pharma has the highest number of patents in addiction followed by, rare diseases. For addiction no patents were filed and 20% of patents were granted in Q1 2024.

Mycosis fungoides related patents lead Innate Pharma portfolio followed by sezary syndrome, and solid tumor

Innate Pharma has highest number of patents in mycosis fungoides followed by sezary syndrome, solid tumor, lymphoma, and nonmelanomatous skin cancer.

For comprehensive analysis of Innate Pharma's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.